Evidence map›Paper›PMID 20161810›Full record

ArticleFrontiers in neuroengineering2010

Bridging the Divide between Neuroprosthetic Design, Tissue Engineering and Neurobiology.

Jennie B Leach, Anil Kumar H Achyuta, Shashi K Murthy

Open access · bronzeAbstract read
In one paragraph

Article in Frontiers in neuroengineering, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 114 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. User-Centered Design of Neuroprosthetics: Advancements and Limitations.CNS & neurological disorders drug targets · 2025
    Review
  6. Short-Term Effects of Gamma Stimulation on Neuroinflammation at the Tissue-Electrode Interface in Motor Cortex.Neuromodulation : journal of the International Neuromodulation Society · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Chronically Implanted Microelectrodes CauseFrontiers in neuroscience · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jennie B LeachDepartment of Chemical and Biochemical Engineering, University of Maryland Baltimore, MD, USA.
Anil Kumar H Achyuta
Shashi K Murthy
University of Maryland, Baltimore · US

Funding

Microenivironment Dimensionality Modulates Neuronal SignalingR01NS065205 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI LEACH, JENNIE B · 2009 to 2012
$1.2M
Coatings for Biostable Chronic Neural ProsthesesR44NS047952 · NINDS · GVD CORPORATION · PI PRYCE LEWIS, HILTON G · 2007 to 2008
$766k
NINDS NIH HHS R01 NS065205NINDS NIH HHS R44 NS047952
6 · The paper itself

Abstract

Neuroprosthetic devices have made a major impact in the treatment of a variety of disorders such as paralysis and stroke. However, a major impediment in the advancement of this technology is the challenge of maintaining device performance during chronic implantation (months to years) due to complex intrinsic host responses such as gliosis or glial scarring. The objective of this review is to bring together research communities in neurobiology, tissue engineering, and neuroprosthetics to address the major obstacles encountered in the translation of neuroprosthetics technology into long-term clinical use. This article draws connections between specific challenges faced by current neuroprosthetics technology and recent advances in the areas of nerve tissue engineering and neurobiology. Within the context of the device-nervous system interface and central nervous system implants, areas of synergistic opportunity are discussed, including platforms to present cells with multiple cues, controlled delivery of bioactive factors, three-dimensional constructs and in vitro models of gliosis and brain injury, nerve regeneration strategies, and neural stem/progenitor cell biology. Finally, recent insights gained from the fields of developmental neurobiology and cancer biology are discussed as examples of exciting new biological knowledge that may provide fresh inspiration toward novel technologies to address the complexities associated with long-term neuroprosthetic device performance.

Indexed as

drug deliverygliosisnerve regenerationneural probesneural progenitorneuroprostheticsignal degradationUtah electrode

Identifiers

PMID20161810
PMCPMC2821180
OpenAlexW2052676697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.